Exact Sciences (EXAS) News Today → What is Nvidia doing on June 10? June 10th is pivotal for Nvidia’s “Silent Partners” (From Weiss Ratings) (Ad) Free EXAS Stock Alerts $45.45 +0.20 (+0.44%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 1 at 6:53 AM | marketbeat.comTD Asset Management Inc Trims Stock Holdings in Exact Sciences Co. (NASDAQ:EXAS)TD Asset Management Inc lowered its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 8.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 385,215 shares of the medical research companyMay 31 at 4:59 PM | marketbeat.comEvoke Wealth LLC Buys New Holdings in Exact Sciences Co. (NASDAQ:EXAS)Evoke Wealth LLC bought a new stake in Exact Sciences Co. (NASDAQ:EXAS - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 31,051 shares of the medical research company's stock, valued at approximately $2,297,000May 31 at 2:18 AM | americanbankingnews.comExact Sciences Co. (NASDAQ:EXAS) Receives $95.40 Consensus PT from AnalystsMay 29, 2024 | marketbeat.comExact Sciences (NASDAQ:EXAS) Shares Down 5.3% Exact Sciences (NASDAQ:EXAS) Stock Price Down 5.3%May 29, 2024 | marketbeat.comExact Sciences Co. (NASDAQ:EXAS) Shares Purchased by Dimensional Fund Advisors LPDimensional Fund Advisors LP lifted its position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 3.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 695,542 shares of the medical resMay 28, 2024 | marketbeat.comEdmond DE Rothschild Holding S.A. Boosts Holdings in Exact Sciences Co. (NASDAQ:EXAS)Edmond DE Rothschild Holding S.A. raised its stake in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 32.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 182,776 shares oMay 28, 2024 | marketbeat.comExact Sciences (NASDAQ:EXAS) Sets New 12-Month Low at $49.12Exact Sciences (NASDAQ:EXAS) Reaches New 52-Week Low at $49.12May 28, 2024 | businesswire.comExact Sciences to Participate in June Investor ConferencesMay 28, 2024 | marketbeat.comExact Sciences Co. (NASDAQ:EXAS) Receives Consensus Rating of "Moderate Buy" from BrokeragesShares of Exact Sciences Co. (NASDAQ:EXAS - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the thirteen ratings firms that are currently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a hold rating and twelve have assignedMay 27, 2024 | finance.yahoo.comHedge Funds are Bullish on This Cancer StockMay 27, 2024 | marketbeat.comArtisan Partners Limited Partnership Increases Stock Position in Exact Sciences Co. (NASDAQ:EXAS)Artisan Partners Limited Partnership lifted its position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 12.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 4,470,278 shares of the medical research company's stMay 27, 2024 | investorplace.comBull Market Blastoff: 3 Stocks Targeting 56% to 91% ReturnsMay 25, 2024 | marketbeat.comBI Asset Management Fondsmaeglerselskab A S Sells 36,605 Shares of Exact Sciences Co. (NASDAQ:EXAS)BI Asset Management Fondsmaeglerselskab A S cut its stake in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 86.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,713 sharesMay 25, 2024 | americanbankingnews.comExact Sciences (NASDAQ:EXAS) Trading Down 5.6%May 24, 2024 | marketbeat.comExact Sciences (NASDAQ:EXAS) Shares Gap Down to $54.08Exact Sciences (NASDAQ:EXAS) Shares Gap Down to $54.08May 24, 2024 | marketbeat.comNorges Bank Buys Shares of 1,626,228 Exact Sciences Co. (NASDAQ:EXAS)Norges Bank bought a new stake in Exact Sciences Co. (NASDAQ:EXAS - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 1,626,228 shares of the medical research company's stock, valued at approximately $120,308,000. NMay 24, 2024 | businesswire.comExact Sciences Demonstrates Continued Leadership in Early Cancer Diagnosis and Improved Health Outcomes for Patients with Multiple Data Presentations at ASCO®May 23, 2024 | marketbeat.comExact Sciences (NASDAQ:EXAS) Shares Down 5.6% Exact Sciences (NASDAQ:EXAS) Shares Down 5.6%May 22, 2024 | businesswire.comCourt Dismisses Exact Sciences' ‘781 Patent Infringement Claim Against GeneoscopyMay 22, 2024 | businesswire.comExact Sciences Earns 2024 Great Place To Work® Certification™May 21, 2024 | bizjournals.comExact Sciences files second patent infringement case against competitorMay 21, 2024 | marketbeat.comExact Sciences (NASDAQ:EXAS) Trading Up 4.5%Exact Sciences (NASDAQ:EXAS) Trading 4.5% HigherMay 21, 2024 | businesswire.comCourt Ruling Enables Exact Sciences to Proceed with Lawsuit against GeneoscopyMay 17, 2024 | marketbeat.comNikko Asset Management Americas Inc. Sells 204,394 Shares of Exact Sciences Co. (NASDAQ:EXAS)Nikko Asset Management Americas Inc. lowered its position in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 10.4% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 1,758,853 shares of the medical research company's stock after selling 204,394 shaMay 17, 2024 | investorplace.comWall Street Favorites: 3 Cathie Wood Stocks With Strong Buy Ratings for May 2024May 16, 2024 | marketbeat.comExact Sciences (NASDAQ:EXAS) Reaches New 12-Month Low at $51.91Exact Sciences (NASDAQ:EXAS) Reaches New 12-Month Low at $51.91May 16, 2024 | markets.businessinsider.comCologuard’s Market Share Surge Powers Buy RatingMay 15, 2024 | marketbeat.comPrincipal Financial Group Inc. Has $65.54 Million Stock Position in Exact Sciences Co. (NASDAQ:EXAS)Principal Financial Group Inc. reduced its position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 13.3% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 885,916 shares of the medical research company's stock afterMay 15, 2024 | marketbeat.comShort Interest in Exact Sciences Co. (NASDAQ:EXAS) Drops By 10.2%Exact Sciences Co. (NASDAQ:EXAS - Get Free Report) was the target of a significant decrease in short interest during the month of April. As of April 30th, there was short interest totalling 8,880,000 shares, a decrease of 10.2% from the April 15th total of 9,890,000 shares. Based on an average trading volume of 2,490,000 shares, the days-to-cover ratio is currently 3.6 days.May 14, 2024 | marketbeat.comEmpire Life Investments Inc. Has $19.51 Million Stake in Exact Sciences Co. (NASDAQ:EXAS)Empire Life Investments Inc. grew its holdings in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 18.5% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 263,689 shares of the medical research company's stock after purchasing an additionalMay 14, 2024 | marketbeat.comExact Sciences (NASDAQ:EXAS) Shares Down 3.7% Exact Sciences (NASDAQ:EXAS) Stock Price Down 3.7%May 11, 2024 | finance.yahoo.comExact Sciences Corporation (NASDAQ:EXAS) First-Quarter Results: Here's What Analysts Are Forecasting For This YearMay 10, 2024 | finance.yahoo.comExact Sciences Corp (EXAS) Q1 2024 Earnings: Revenue Growth Amidst Increased Net LossMay 10, 2024 | marketbeat.comQ4 2025 EPS Estimates for Exact Sciences Co. (NASDAQ:EXAS) Lowered by Leerink PartnrsExact Sciences Co. (NASDAQ:EXAS - Free Report) - Stock analysts at Leerink Partnrs cut their Q4 2025 earnings per share estimates for Exact Sciences in a research report issued to clients and investors on Thursday, May 9th. Leerink Partnrs analyst P. Souda now anticipates that the medical researcMay 10, 2024 | markets.businessinsider.comOptimistic Outlook for Exact Sciences: Overcoming Challenges with Growth Initiatives and New Product PotentialMay 10, 2024 | finance.yahoo.comExact Sciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS LagsMay 10, 2024 | businesswire.comThe National Institute for Health and Care Excellence (NICE) Recommends Use of Exact Sciences' Oncotype DX® Test to Help Guide Chemotherapy Decisions for Node-positive Breast Cancer PatientsMay 9, 2024 | markets.businessinsider.comPiper Sandler Keeps Their Buy Rating on Exact Sciences (EXAS)May 9, 2024 | markets.businessinsider.comBuy Rating Affirmed for Exact Sciences on Strong Performance and Promising Growth InitiativesMay 9, 2024 | markets.businessinsider.comBuy Rating Reiterated for Exact Sciences on Strong Q1 Performance and Positive Financial OutlookMay 9, 2024 | finance.yahoo.comQ1 2024 Exact Sciences Corp Earnings CallMay 9, 2024 | finance.yahoo.comExact Sciences Stock, A Cathie Wood Darling, Tumbles On 'Overblown' Growth ConcernsMay 9, 2024 | finance.yahoo.comExact Sciences Corporation (NASDAQ:EXAS) Q1 2024 Earnings Call TranscriptMay 9, 2024 | marketbeat.comExact Sciences (NASDAQ:EXAS) Hits New 52-Week Low at $53.63Exact Sciences (NASDAQ:EXAS) Hits New 1-Year Low at $53.63May 9, 2024 | benzinga.comExact Sciences Reports Q1 Loss, Joins Beyond Meat, Duolingo And Other Big Stocks Moving Lower In Thursday's Pre-Market SessionMay 9, 2024 | finance.yahoo.comExact Sciences Corp (EXAS) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth ...May 9, 2024 | marketbeat.comLos Angeles Capital Management LLC Acquires New Position in Exact Sciences Co. (NASDAQ:EXAS)Los Angeles Capital Management LLC bought a new position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 18,142 shares of the medical research compaMay 9, 2024 | markets.businessinsider.comBuy Rating Affirmed for Exact Sciences Amidst Strong Growth and Innovative PipelineMay 9, 2024 | msn.comExact Sciences (EXAS) Q1 2024 Earnings Call TranscriptMay 8, 2024 | finance.yahoo.comExact Sciences Announces First-Quarter 2024 Results Get Exact Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EXAS and its competitors with MarketBeat's FREE daily newsletter. Email Address What is Nvidia doing on June 10? June 10th is pivotal for Nvidia’s “Silent Partners” (Ad)A small handful of companies are working with Nvidia to help ensure that this pivot is a massive success. We call them Nvidia’s “Silent Partners.” Click here to find out who they are. EXAS Media Mentions By Week EXAS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EXAS News Sentiment▼0.850.76▲Average Medical News Sentiment EXAS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EXAS Articles This Week▼138▲EXAS Articles Average Week Get Exact Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EXAS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Charles River Laboratories International News Medpace News National Research News ICON Public News Biogen News Alnylam Pharmaceuticals News BioMarin Pharmaceutical News Neurocrine Biosciences News Incyte News United Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EXAS) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…StocksToTradeTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden Nomination CANCELED?The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap Profits[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaBiden replacement revealed?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exact Sciences Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
